Difficulty: Medium
Average Score: 84%
Practice
Which one of the following drugs is most likely to increase plasma levels of alprazolam, theophylline, and warfarin?
Correct answer
B
Rationale
In this question, the correct answer is B) Fluvoxamine. Fluvoxamine is a potent inhibitor of the cytochrome P450 enzyme CYP1A2, which is responsible for the metabolism of alprazolam, theophylline, and warfarin. By inhibiting this enzyme, fluvoxamine can increase the plasma levels of these drugs, leading to potential drug interactions and toxicity.
Desipramine (option A) and Imipramine (option C) are tricyclic antidepressants that do not have a significant effect on the metabolism of alprazolam, theophylline, or warfarin, making them less likely to increase their plasma levels.
Nefazodone (option D) is a serotonin modulator and stimulator that does not have a significant effect on CYP1A2 metabolism, so it is also less likely to increase the plasma levels of alprazolam, theophylline, or warfarin.
Understanding drug interactions and how different medications can affect the metabolism of others is crucial in pharmacology to prevent adverse effects and ensure the safe and effective use of medications in clinical practice. Fluvoxamine's potent inhibition of CYP1A2 underscores the importance of considering potential drug interactions when prescribing medications to patients taking alprazolam, theophylline, or warfarin.
Desipramine (option A) and Imipramine (option C) are tricyclic antidepressants that do not have a significant effect on the metabolism of alprazolam, theophylline, or warfarin, making them less likely to increase their plasma levels.
Nefazodone (option D) is a serotonin modulator and stimulator that does not have a significant effect on CYP1A2 metabolism, so it is also less likely to increase the plasma levels of alprazolam, theophylline, or warfarin.
Understanding drug interactions and how different medications can affect the metabolism of others is crucial in pharmacology to prevent adverse effects and ensure the safe and effective use of medications in clinical practice. Fluvoxamine's potent inhibition of CYP1A2 underscores the importance of considering potential drug interactions when prescribing medications to patients taking alprazolam, theophylline, or warfarin.